Concord, CA and Mountain View, CA,
October 5, 2005
Siemens Medical Solutions and IMPAC Medical Systems Inc.,
part of the Elekta Group and a leading provider of information
technology solutions for oncology care, today announced a
five-year extension of their software distribution agreement,
which enables Siemens to distribute its LANTIS® Oncology
Information System, based upon IMPAC’s integrated clinical and
administrative management systems, to oncology practices
worldwide.
Under the terms of the agreement, Siemens can package IMPAC’s
radiation oncology management software with its oncology
treatment solutions to address the comprehensive needs of
today’s oncology departments, and will continue to cooperate in
the development and marketing of IMPAC products.
“Our relationship with IMPAC has been in effect since 1992, and
the fact that we will remain partners in oncology solutions is a
testament to our willingness to work together to provide the
oncology community with comprehensive solutions for clinical and
administrative practice management,” said Ajit Singh, PhD,
president of Siemens Medical Solutions, Oncology Care Systems
division. ”Our current and future customers will continue to
benefit from this agreement.”
“IMPAC is pleased that we have extended our agreement with
Siemens,” stated James Hoey, IMPAC president and CEO, “and it is
clear that both companies continue to fully embrace an open
systems environment that enables our customers to pursue
best-of-breed solutions. We encourage all manufacturers to do
the same.”
“Standards development and adoption are long overdue in
radiation oncology and this partnership allows us to direct more
of our development dollars towards the advancement of clinical
solutions and less on maintaining compatibility with proprietary
systems, “noted Joseph K. Jachinowski, executive vice president
of product creation for the Elekta Group.
********
For more information, please contact:
Julie DeSantis, Public Relations Manager
IMPAC Medical Systems, Inc.
Tel: +1 650-623-8883, e-mail:
jdesantis@impac.com
Amanda Naiman, Manager, Media Relations
Siemens Medical Solutions
Tel: +1 610 448-4531, email: amanda.naiman@siemens.com
Investor Enquiries:
International: Peter Ejemyr, Group VP Corporate Communications,
Elekta AB
Tel: +46 733 611 000, e-mail: peter.ejemyr@elekta.com
United States: Lars Jonsteg, VP Investor Relations North
America, Elekta Inc.
Tel: +46 708-783 735, e-mail: lars.jonsteg@elekta.com
About Siemens
Medical Solutions
Siemens Medical Solutions of Siemens AG (NYSE: SI) with
headquarters in Malvern, Pennsylvania and Erlangen, Germany, is
one of the largest suppliers to the healthcare industry in the
world. The company is known for bringing together innovative
medical technologies, healthcare information systems, management
consulting, and support services, to help customers achieve
tangible, sustainable, clinical and financial outcomes.
Employing approximately 31,000 people worldwide and operating in
more than 120 countries, Siemens Medical Solutions reported
sales of 7.07 billion EUR, orders of 8.12 billion EUR and group
profit of 1.05 billion EUR for fiscal 2004. More information can
be obtained by visiting
http://www.usa.siemens.com/medical-pressroom.
About IMPAC Medical Systems, Inc.
IMPAC Medical Systems, Inc., a company in the Elekta Group,
provides healthcare IT solutions that streamline clinical and
business operations across the spectrum of cancer care. IMPAC’s
open integration to multiple healthcare data and imaging systems
offers oncology-specific patient charting and practice
management, as well as best-of-breed systems for anatomic
pathology, clinical laboratory, and cancer registry. With
products that range from diagnosis and treatment through
long-term follow-up, IMPAC provides a comprehensive oncology
management solution that helps improve overall communication,
process efficiency, and quality patient care. For more
information about IMPAC’s products or services, please call
888-GO-IMPAC or visit www.impac.com.
About
Elekta
Elekta is an international medical-technology Group, providing
meaningful clinical solutions, comprehensive information systems
and services for improved cancer care and management of brain
disorders. All of Elekta’s solutions employ non-invasive or
minimally invasive techniques and are therefore clinically
effective, gentle on the patient and cost-effective. With
approx. 1700 employees, Elekta’s corporate headquarters is
located in Stockholm, Sweden and the company is listed on the
Stockholm Stock Exchange under the ticker EKTAb. For more
information about Elekta’s products or services, please visit
www.elekta.com. |
